Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure

Overview of attention for article published in Frontiers in immunology, August 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 69,191 followers.

RT @ImmuneGC_Papers: GC | Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure https:…

30 Aug 2022

Reply Repost Favourite

GC | Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure https://t.co/rsbMfUz862

29 Aug 2022

Reply Repost Favourite

Persistent but atypical GC reaction among 3rd SARSCoV2 vac after rituximab exposure: After 3rd vac, 5/7 seroconverted RTX gv⬇️anti-SARSCoV2 IgG but similar neutralizing capacity vs HC. Abs after 3rd vac correlate after 2nd vac. https://t.co/lha0XwxpB2

11 Aug 2022

Reply Repost Favourite

New Research: Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure: Background Durable vaccine-mediated immunity relies on the generation of long-lived plasma cells and memory B cells… https://t.co/j4Z

11 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.